Thus, reactivation of p53 could be carried out by designing inhibitors of MDM2-p53 interaction, where it was demonstrated that MDM2 inhibitors could induce apoptosis and sensitize lung cancer cells to chemotherapy (25, 26). The gene discussed is MDM2; the disease is lung carcinoma.